Related Experiment Videos
Hereditary multiple exostoses: report of a kindred
Journal of Medical Genetics
|December 1, 1981
Summary
The risk of malignancy in multiple hereditary exostoses (MHE) is lower than previously thought, closer to 3% or less. This finding is crucial for accurate patient counseling regarding cancer risk in MHE.
Area of Science:
- Genetics
- Oncology
- Orthopedics
Background:
- Multiple hereditary exostoses (MHE) is a genetic disorder characterized by the development of numerous bone tumors (exostoses).
- The reported incidence of malignant transformation (sarcomatous degeneration) in MHE lesions varies widely in the literature, often cited between 10% and 25%.
Observation:
- A study of a large family with 37 members affected by MHE found only one instance of sarcomatous degeneration.
- A systematic review of existing literature indicated significant sampling errors in previous studies.
- These errors likely led to an overestimation of the true risk of malignancy in MHE.
Findings:
- In large pedigrees with comprehensive ascertainment, the actual risk of sarcomatous degeneration in MHE is estimated to be approximately 3% or lower.
- This revised risk assessment challenges previously accepted figures.
Implications:
- The findings suggest a need to revise current risk counseling for individuals with MHE.
- Accurate risk assessment is essential for appropriate patient management and psychological support.
- Further research with robust methodologies is warranted to confirm these estimates.